Be a guest or sponsor our podcasts - learn more about us : 800 665 0411

Share on StockTwits

Global Healthcare to Soar Above $2 Trillion in 2020 with Consumerism and Outcome-based Care Models

High adoption of annuity-based reimbursement programs by payers and therapy manufacturers will unlock the potential of gene therapies, finds Frost & Sullivan


Santa Clara, Calif. - February 18, 2020 ( Newswire) Despite rising trade tension and a sluggish economic outlook for 2020, the global healthcare industry is set for an invigorating year due to a partial realization of major healthcare policies and initiatives and technology advancements. Moreover, value-based care is driving the adoption and need for consumer-centric targeted therapies. Retail giants such as Amazon, Walmart, CVS, Ali Health, and Best Buy will continue to make further headway into the individual care space, driving the "comparison shopping" consumer trend for healthcare services and products. With these trends, the overall global healthcare market is poised to register a 5.3% growth in 2020 and exceed $2 trillion in manufacturer revenue.

Frost & Sullivan's recent analysis, Global Healthcare Market Outlook, 2020, analyzes actionable insights and predictions for key technologies, regional trends, and major healthcare growth opportunities in 2020. The key sectors covered include pharmaceuticals and biotechnology, in-vitro diagnostics (IVD), medical technologies, medical imaging equipment, and healthcare IT (HIT).

For further information on this analysis or to schedule an interview, please contact

"Interoperability will finally take a major step forward in terms of government policies, vendor acceptance, and providers' and payers' focus on investing in healthcare IT (HIT) systems and medical technology-integrated platform solutions," said Kamaljit Behera, Senior Industry Analyst, Transformational Health. "Furthermore, despite artificial intelligence (AI) in the medical imaging market crossing $400 million in 2020, start-ups and innovators will be compelled to rethink data science practices to convince the community of fair, ethical, and no-harm use."

Increased adoption of annuity-based specialized reimbursement programs by private insurance companies and therapy manufacturers will unlock the commercialization potential of gene therapies. Precision medicine informatics platforms capable of leveraging genomic, clinical, financial, and lifestyle data sets will gain market traction.

Regionally, there are considerable growth opportunities in:

  • The United States: Technology-savvy healthcare consumers that receive healthcare coverage from their employers will continue to request and actively pursue telehealth technology, replacing in-person visits with their providers.
  • Europe: Shifting economics, population, and behavior dynamics will lead to a rise in healthcare expenditure in many European countries. Addressing long-pending digital health objectives will be a strategic priority in 2020.
  • The Middle East: Increased local manufacturing and government spending on lifestyle diseases will be key driving factors, mainly across the Gulf Cooperation Council (GCC) countries.
  • Asia-Pacific: China's aggressive policymaking creates a positive outlook, especially for innovator biologics, medical devices, and digital solutions.
  • Latin America: Virtual and home care segments are expected to witness high growth in major countries such as Colombia, Argentina, Chile, and Mexico.

Global Healthcare Market Outlook, 2020 is part of Frost & Sullivan's global Transformational Health Growth Partnership Service program.

About Frost & Sullivan

For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.


Mariana Fernandez
Corporate Communications
T: +1 210 348 10 12
T: +54 11 4778 3540

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Global investors must adhere to regulations of each country. Please read privacy policy:

Follow Us on StockTwits - A Leading Global Investor Website for Biotech Industry Stocks - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks